Signifier Medical Technologies Announces Upcoming Publication of Randomized Controlled Trial Results Examining High-Intensity (Active) Vs. Low-Intensity (Sham) Neuromuscular Electrical Stimulation in Patients for 6 Weeks

Contributed by: Business Wire

Logo

Tags

Neurology

Venture Capital

Health

Medical Devices

Health Technology

Professional Services

Clinical Trials

Other Health

Signifier Medical Technologies LLC

More Like This

Signifier Medical Technologies Announces Publication of a New Study Exploring Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea

Signifier Medical Technologies Announces Milestone Order of 10,000 eXciteOSA Devices by Leading Home Medical Equipment Provider, Spectrum Sleep Solutions Inc.

Signifier Medical Technologies Secures European Union Medical Device Regulation (EU MDR) Certification for eXciteOSA®

CMS Sets Pricing with New HCPCS Codes for eXciteOSA Therapy, Expanding Access to Innovative Daytime Sleep Apnea Treatment

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints

Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France